ICMR Director-General discusses vaccination status and strategy in India, read the details here


As per scientific research data, antibodies formed after contracting the COVID-19 causing coronavirus to prevail against the virus for six to twelve months. But, how long do the vaccine-generated antibodies remain in the body? As of now, there isn’t any accurate scientific evidence for the time frame of sustainability of vaccine-generated antibodies. Predictably, the evidence may take some time to show up in certified journals because only six to seven months have passed since the start of vaccination all over the world.

ICMR Director-General Dr. Balram Bhargava said that investigation and analysis play an important role in overcoming any pandemic. Currently, India is testing 1400 people every day for a population of one million, which is 10 times more than the standards set by the World Health Organization (WHO). Moreover, during the second wave, the concerned authorities have carried out rapid analysis, authentication, and investigation of the rising cases which has played a key role in calming down the deadly second wave.

Dr. Bhargava said that at present there is more than ten percent infection rate in 73 districts. Whereas in 65 districts, this rate is between five and ten percent. Fortunately, the infection rate in about 595 districts is less than five percent. These numbers are weekly infection rates, on the basis of which it can be said that most of the states of the country have emerged out of the second wave. As per the guidelines, a satisfactory condition is considered when the infection rate is less than five percent.

Furthermore, Dr. Bhargava told that the ICMR is working on another booster dose of Covaxin. The booster dose, which is being developed by the ICMR, can be taken six months after taking two doses. However, the work on this booster dose is in its initial stages. Therefore, it may take some time to get detailed data on this booster dose.

Related posts